Website Under Development
Innovating in Psilocybin Science
Psilotech Pharma is a pharmaceutical biotechnology company headquartered in Jamaica, specialising in the cultivation, extraction, and global distribution of psilocybin mushrooms for approved medical and research use.
Our mission is to advance the clinical understanding and pharmaceutical application of psilocybin through compliant production and strategic collaboration with global research institutions and life science partners.
Clinical Trial Supply
GMP-grade cultivation and preparation of psilocybin materials to support regulated clinical trials and investigational studies worldwide.
Micro- and Macro-Dosing Formulations
GMP-grade cultivation and preparation of psilocybin materials to support regulated clinical trials and investigational studies worldwide.
Pharmaceutical Extraction
High-purity psilocybin oil extraction for integration into pharmaceutical R&D pipelines and formulation development.
Licensed Export & Distribution
Fully authorised export to qualified partners in jurisdictions where psilocybin use has been legalised for scientific or medical purposes.
Beyond mental-health therapeutics
Psilotech Pharma supports research and development in:
• Neuroscience and Cognitive Function
• Addiction and Behavioural Health
• Pain and Inflammation Management
• Neurodegenerative Disorders
• Pharmacological and Biochemical Studies
Operating under Jamaica’s regulatory framework for psychedelic research, Psilotech Pharma adheres to rigorous standards in safety, traceability, and ethical governance.
Our goal is to enable safe, transparent, and scalable access to pharmaceutical-grade psilocybin for global innovation across neuroscience, behavioural health, and chronic condition research.